Catalyst Wire Dossier Catalyst Wire Dossier

Anagrelide Controlled Release (GALE-401)

anagrelide · Galena Biopharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anagrelide Controlled Release (GALE-401), covering 2017-02-27 to 2017-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders [Phase 2]

See pricing